Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Biotage AB (publ) · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2028 | $3.37B | $3.03B - $3.71B | $860.70M | $7.163 | 1 |
| Dec 2027 | $2.15B | $1.94B - $2.37B | $549.68M | $4.618 | 1 |
| Dec 2026 | $1.98B | $1.78B - $2.17B | $504.00M | $4.064 | 2 |
| Dec 2025 | $1.83B | $1.68B - $1.97B | $465.86M | $3.223 | 2 |
| Dec 2024 | $2.12B | $2.07B - $2.16B | $539.69M | $3.651 | 2 |
| Dec 2023 | $1.75B | $1.59B - $1.92B | $447.71M | $2.905 | 1 |
| Dec 2022 | $1.55B | $1.41B - $1.69B | $395.87M | $4.012 | 1 |
| Dec 2021 | $1.21B | $1.10B - $1.33B | $309.79M | $3.273 | 1 |
| Dec 2020 | $1.07B | $973.26M - $1.17B | $273.25M | $2.665 | 1 |
| Dec 2019 | $1.06B | $961.73M - $1.16B | $270.01M | $3.114 | 1 |
| Dec 2018 | $927.61M | $842.88M - $1.01B | $236.64M | $2.781 | 1 |
| Dec 2017 | $777.13M | $706.15M - $848.12M | $198.26M | $2.148 | 1 |